The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Neuroprotection by minocycline facilitates significant recovery from spinal cord injury in mice
Abstract
Acute spinal cord injury (SCI) produces tissue damage that continues to evolve days and weeks after the initial insult, with corresponding functional impairments. Reducing the extent of progressive tissue loss ('neuroprotection') following SCI should result in a better recovery from SCI, but treatment options have thus far been limited. In this study, we have tested the efficacy of minocycline in ameliorating damage following acute SCI in mice. This semi-synthetic tetracycline antibiotic has been reported to inhibit the expression and activity of several mediators of tissue injury, including inflammatory cytokines, free radicals and matrix metalloproteinases, making it a suitable candidate for study. Mice were subjected to extradural compression of the spinal cord using a modified aneurysm clip, following which they received treatment with either minocycline or vehicle beginning 1 h after injury. Behavioural testing of hindlimb function was initiated 3 days after injury using the Basso Beattie Bresnahan locomotor rating scale, and at 1 week using the inclined plane test. Functional assessments demonstrated that minocycline administration significantly improved both hindlimb function and strength from 3 to 28 days after injury compared with vehicle controls. Furthermore, gross lesion size in the spinal cord was significantly reduced by minocycline, and there was evidence of axonal sparing as determined using fluorogold labelling of the rubrospinal tract and by Bielchowsky silver stain. Finally, a comparison of minocycline against the currently approved treatment for acute SCI in humans, methylprednisolone, demonstrated superior behavioural recovery in the minocycline-treated animals.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Sensitive and Reliable Locomotor Rating Scale for Open Field Testing in Rats
BASSO, D. M., BEATTIE, M. S., & BRESNAHAN, J. C. (1995) · Journal of Neurotrauma · doi:10.1089/neu.1995.12.1 · Cited by 3,963
Epidemiology, Demographics, and Pathophysiology of Acute Spinal Cord Injury
Sekhon, L. H. S., & Fehlings, M. G. (2001) · Spine · doi:10.1097/00007632-200112151-00002 · Cited by 1,434
Wu, D. C., Jackson-Lewis, V., Vila, M., Tieu, K., Teismann, P., Vadseth, C., Choi, D.-K., Ischiropoulos, H., & Przedborski, S. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-05-01763.2002 · Cited by 1,183 · cited 3×
“…SCI is that this drug is proving to have widespread ef®cacy in limiting the pathology of animal models of CNS diseases including Parkinson's disease (Wu et al., 2002), Huntington's disease (Chen et al., 2000), stroke (Yrjanheikki et al., 1999), multiple sclerosis (Brundula et al., 2002; Popovic et…”
BackgroundGreenberg, M. S. (2016) · Thieme eBooks · doi:10.1055/b-006-149702 · Cited by 1,170
Zhu, S., Stavrovskaya, I. G., Drozda, M., Kim, B. Y. S., Ona, V., Li, M., Sarang, S., Liu, A. S., Hartley, D. M., Wu, D. C., et al. (2002) · Nature · doi:10.1038/417074a · Cited by 1,067
Metalloproteinases in biology and pathology of the nervous system
Yong, V. W., Power, C., Forsyth, P., & Edwards, D. R. (2001) · Nature Reviews Neuroscience · doi:10.1038/35081571 · Cited by 1,060
Chen, M., Ona, V. O., Li, M., Ferrante, R. J., Fink, K. B., Zhu, S., Bian, J., Guo, L., Farrell, L. A., Hersch, S. M., et al. (2000) · Nature Medicine · doi:10.1038/77528 · Cited by 1,051
Yrjänheikki, J., Tikka, T., Keinänen, R., Goldsteins, G., Chan, P. H., & Koistinaho, J. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.23.13496 · Cited by 1,038
Tikka, T., Fiebich, B. L., Goldsteins, G., Keinänen, R., & Koistinaho, J. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-08-02580.2001 · Cited by 958
Acute Spinal Cord Injury, Part I: Pathophysiologic Mechanisms
Dumont, R. J., Okonkwo, D. O., Verma, S., Hurlbert, R. J., Boulos, P. T., Ellegala, D. B., & Dumont, A. S. (2001) · Clinical Neuropharmacology · doi:10.1097/00002826-200109000-00002 · Cited by 732
Cited by
Ahuja, C. S., Wilson, J. R., Nori, S., Kotter, M. R. N., Druschel, C., Curt, A., & Fehlings, M. G. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.18 · Cited by 2,441
Self-citationBasso, D. M., Fisher, L. C., Anderson, A. J., Jakeman, L. B., Mctigue, D. M., & Popovich, P. G. (2006) · Journal of Neurotrauma · doi:10.1089/neu.2006.23.635 · Cited by 1,699
Kim, S.-H., Turnbull, J., & Guimond, S. (2011) · Journal of Endocrinology · doi:10.1530/joe-10-0377 · Cited by 1,166
Minocycline: Far beyond an Antibiotic
Garrido‐Mesa, N., Zarzuelo, A., & Gálvez, J. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12139 · Cited by 935
Traumatic Spinal Cord Injury—Repair and Regeneration
Ahuja, C. S., Nori, S., Tetreault, L., Wilson, J., Kwon, B., Harrop, J., Choi, D., & Fehlings, M. G. (2017) · Neurosurgery · doi:10.1093/neuros/nyw080 · Cited by 923
From basics to clinical: A comprehensive review on spinal cord injury
Silva, N. A., Sousa, N., Reis, R. L., & Salgado, A. J. (2014) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2013.11.002 · Cited by 814
Secondary injury mechanisms in traumatic spinal cord injury: a nugget of this multiply cascade
Oyinbo, C. (2011) · Acta Neurobiologiae Experimentalis · doi:10.55782/ane-2011-1848 · Cited by 786
Spinal cord injury: molecular mechanisms and therapeutic interventions
Hu, X., Xu, W., Ren, Y., Wang, Z., He, X., Huang, R., Ma, B., Zhao, J., Zhu, R., & Cheng, L. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01477-6 · Cited by 770
Neuroinflammation after traumatic brain injury: Opportunities for therapeutic intervention
Kumar, A., & Loane, D. J. (2012) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2012.06.008 · Cited by 710
Role of Microglia in Neurotrauma
Loane, D. J., & Byrnes, K. R. (2010) · Neurotherapeutics · doi:10.1016/j.nurt.2010.07.002 · Cited by 657
Mitochondrial calcium and the permeability transition in cell death
Lemasters, J. J., Theruvath, T. P., Zhong, Z., & Nieminen, A.-L. (2009) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2009.06.009 · Cited by 654
Activated Microglia Contribute to the Maintenance of Chronic Pain after Spinal Cord Injury
Hains, B. C., & Waxman, S. G. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.0003-06.2006 · Cited by 640
Pineau, I., & Lacroix, S. (2007) · Journal of Comparative Neurology · doi:10.1002/cne.21149 · Cited by 590
Gupta, D., Tator, C. H., & Shoichet, M. S. (2006) · Biomaterials · doi:10.1016/j.biomaterials.2005.11.015 · Cited by 584
Metalloproteinases: Mediators of Pathology and Regeneration in the CNS
Yong, V. W. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1807 · Cited by 582
“This increase is time-dependent, with elevations in MMP3, 7, 10, 11, 19 and 20 observed within 24 h of injury, and the rest within 5 day”
BackgroundSelf-citationThe Promise of Minocycline in Neurology
Yong, V. W., Wells, J., Giuliani, F., Casha, S., Power, C., & Metz, L. M. (2004) · The Lancet Neurology · doi:10.1016/s1474-4422(04)00937-8 · Cited by 518
Stirling, D. P., Khodarahmi, K., Liu, J., McPhail, L. T., McBride, C. B., Steeves, J. D., Ramer, M. S., & Tetzlaff, W. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.5275-03.2004 · Cited by 507
Corneal nerves in health and disease
Shaheen, B. S., Bakir, M., & Jain, S. (2014) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2013.09.002 · Cited by 474
Peng, W., Cotrina, M. L., Han, X., Yu, H., Bekar, L., Blum, L., Takano, T., Tian, G.-F., Goldman, S. A., & Nedergaard, M. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0902531106 · Cited by 424
Results of a phase II placebo-controlled randomized trial of minocycline in acute spinal cord injury
Casha, S., Zygun, D., McGowan, M. D., Bains, I., Yong, V. W., & John Hurlbert, R. (2012) · Brain · doi:10.1093/brain/aws072 · Cited by 408
Teng, Y. D., Choi, H., Onario, R. C., Zhu, S., Desilets, F. C., Lan, S., Woodard, E. J., Snyder, E. Y., Eichler, M. E., & Friedlander, R. M. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0306239101 · Cited by 335
Neurogenic inflammation after traumatic brain injury and its potentiation of classical inflammation
Corrigan, F., Mander, K. A., Leonard, A. V., & Vink, R. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0738-9 · Cited by 331
Gris, D., Marsh, D. R., Oatway, M. A., Chen, Y., Hamilton, E. F., Dekaban, G. A., & Weaver, L. C. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.5343-03.2004 · Cited by 319
REVIEW OF TREATMENT TRIALS IN HUMANSPINAL CORD INJURY: ISSUES, DIFFICULTIES, AND RECOMMENDATIONS
Tator, C. H. (2006) · Neurosurgery · doi:10.1227/01.neu.0000245591.16087.89 · Cited by 303
Badhiwala, J. H., Ahuja, C. S., & Fehlings, M. G. (2019) · Journal of Neurosurgery: Spine · doi:10.3171/2018.9.spine18682 · Cited by 288
Kwon, B. K., Okon, E., Hillyer, J., Mann, C., Baptiste, D., Weaver, L. C., Fehlings, M. G., & Tetzlaff, W. (2011) · Journal of Neurotrauma · doi:10.1089/neu.2009.1149 · Cited by 280
Minocycline as a Neuroprotective Agent
Stirling, D. P., Koochesfahani, K. M., Steeves, J. D., & Tetzlaff, W. (2005) · The Neuroscientist · doi:10.1177/1073858405275175 · Cited by 279
Yune, T. Y., Lee, J. Y., Jung, G. Y., Kim, S. J., Jiang, M. H., Kim, Y. C., Oh, Y. J., Markelonis, G. J., & Oh, T. H. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.1661-07.2007 · Cited by 270
Pharmacological Approaches To Repair the Injured Spinal Cord
Baptiste, D. C., & Fehlings, M. G. (2006) · Journal of Neurotrauma · doi:10.1089/neu.2006.23.318 · Cited by 269
Hawryluk, G. W. J., Rowland, J., Kwon, B. K., & Fehlings, M. G. (2008) · Neurosurgical Focus · doi:10.3171/foc.2008.25.11.e14 · Cited by 252
The benefits and detriments of macrophages/microglia in models of multiple sclerosis
Rawji, K. S., & Yong, V. W. (2013) · Clinical and Developmental Immunology · doi:10.1155/2013/948976 · Cited by 217
“…with minocycline, an antibiotic that has been thought to reduce the activation of macrophages/microglia and the expression of inflammatory cytokines and matrix metalloproteinases (MMPs), reduced the amount of phagocytic cells in the lesion site, leading to a greater neurological recovery [23–25].”
BackgroundClinical Potential of Minocycline for Neurodegenerative Disorders
BLUM, D., CHTARTO, A., TENENBAUM, L., BROTCHI, J., & LEVIVIER, M. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.07.012 · Cited by 157
Ontogeny and Functions of Central Nervous System Macrophages
Katsumoto, A., Lu, H., Miranda, A. S., & Ransohoff, R. M. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1400716 · Cited by 149
Minocycline inhibits oxidative stress and decreases in vitro and in vivo ischemic neuronal damage
Morimoto, N., Shimazawa, M., Yamashima, T., Nagai, H., & Hara, H. (2005) · Brain Research · doi:10.1016/j.brainres.2005.02.062 · Cited by 137
The Potential of Minocycline for Neuroprotection in Human Neurologic Disease
Zemke, D., & Majid, A. (2004) · Clinical Neuropharmacology · doi:10.1097/01.wnf.0000150867.98887.3e · Cited by 125
“Treatment beginning 1 hour after spinal cord trauma in the mouse produced increased recovery of hind limb function and strength in as early as 3 days, and continued improvement was seen out to 28 days.(45) The lesion size was significantly decreased, and more intact axons were found within the rubrospinal tract.”
BackgroundUtari, A., Chonchaiya, W., Rivera, S. M., Schneider, A., Hagerman, R. J., Faradz, S. M. H., Ethell, I. M., & Nguyen, D. V. (2010) · American Journal on Intellectual and Developmental Disabilities · doi:10.1352/1944-7558-115.5.433 · Cited by 105
Minocycline development for acute ischemic stroke
Fagan, S. C., Cronic, L. E., & Hess, D. C. (2011) · Translational Stroke Research · doi:10.1007/s12975-011-0072-6 · Cited by 100
Activated microglia targeting dendrimer–minocycline conjugate as therapeutics for neuroinflammation.
Sharma, R., Kim, S.-Y., Sharma, A., Zhang, Z., Kambhampati, S. P., Kannan, S., & Kannan, R. M. (2017) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.7b00569 · Cited by 100
Antibiotics and the nervous system: More than just the microbes?
Champagne-Jorgensen, K., Kunze, W. A., Forsythe, P., Bienenstock, J., & McVey Neufeld, K.-A. (2019) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2018.12.014 · Cited by 92
Animal studies in spinal cord injury: A systematic review of methylprednisolone
Akhtar, A. Z., Pippin, J. J., & Sandusky, C. B. (2009) · Alternatives to Laboratory Animals · doi:10.1177/026119290903700108 · Cited by 54
Metadata
- Authors
- Wells, J. E. A.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2003-04-22
- Volume
- 126
- Issue
- 7
- Pages
- 1628-1637
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2133132296
- Cited by
- 422
- References
- 41
- FWCI
- 14.55
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.